180 related articles for article (PubMed ID: 31614566)
21. Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").
Pellett S; Tepp WH; Lin G; Johnson EA
Toxicon; 2018 Jun; 147():38-46. PubMed ID: 29273248
[TBL] [Abstract][Full Text] [Related]
22. Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins.
Kalb SR; Baudys J; Egan C; Smith TJ; Smith LA; Pirkle JL; Barr JR
Appl Environ Microbiol; 2011 Feb; 77(4):1301-8. PubMed ID: 21169446
[TBL] [Abstract][Full Text] [Related]
23. High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.
Carle S; Pirazzini M; Rossetto O; Barth H; Montecucco C
Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29257047
[TBL] [Abstract][Full Text] [Related]
24. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
25. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
[TBL] [Abstract][Full Text] [Related]
26. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
[TBL] [Abstract][Full Text] [Related]
27. Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology.
von Berg L; Stern D; Pauly D; Mahrhold S; Weisemann J; Jentsch L; Hansbauer EM; Müller C; Avondet MA; Rummel A; Dorner MB; Dorner BG
Sci Rep; 2019 Apr; 9(1):5531. PubMed ID: 30940836
[TBL] [Abstract][Full Text] [Related]
28. Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.
He Y; Elias CL; Huang YC; Gao X; Leung YM; Kang Y; Xie H; Chaddock JA; Tsushima RG; Gaisano HY
Pancreas; 2008 Jan; 36(1):10-7. PubMed ID: 18192874
[TBL] [Abstract][Full Text] [Related]
29. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.
Hallis B; James BA; Shone CC
J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885
[TBL] [Abstract][Full Text] [Related]
30. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
Dolly JO; Wang J; Zurawski TH; Meng J
FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
[TBL] [Abstract][Full Text] [Related]
31. Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.
Elliott M; Maignel J; Liu SM; Favre-Guilmard C; Mir I; Farrow P; Hornby F; Marlin S; Palan S; Beard M; Krupp J
PLoS One; 2017; 12(10):e0185628. PubMed ID: 28982136
[TBL] [Abstract][Full Text] [Related]
32. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
33. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
[TBL] [Abstract][Full Text] [Related]
34. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
Lawrence GW; Wang J; Brin MF; Aoki KR; Wheeler L; Dolly JO
FEBS J; 2014 Jul; 281(14):3243-60. PubMed ID: 24863955
[TBL] [Abstract][Full Text] [Related]
35. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
36. Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons.
Joussain C; Le Coz O; Pichugin A; Marconi P; Lim F; Sicurella M; Salonia A; Montorsi F; Wandosell F; Foster K; Giuliano F; Epstein AL; Aranda Muñoz A
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791373
[TBL] [Abstract][Full Text] [Related]
37. On the action of botulinum neurotoxins A and E at cholinergic terminals.
Washbourne P; Pellizzari R; Rossetto O; Bortoletto N; Tugnoli V; De Grandis D; Eleopra R; Montecucco C
J Physiol Paris; 1998 Apr; 92(2):135-9. PubMed ID: 9782457
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5.
Kalb SR; Baudys J; Webb RP; Wright P; Smith TJ; Smith LA; Fernández R; Raphael BH; Maslanka SE; Pirkle JL; Barr JR
FEBS Lett; 2012 Jan; 586(2):109-15. PubMed ID: 22172278
[TBL] [Abstract][Full Text] [Related]
39. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
Lawrence GW; Foran P; Dolly JO
Eur J Biochem; 1996 Mar; 236(3):877-86. PubMed ID: 8665909
[TBL] [Abstract][Full Text] [Related]
40. A label-free biosensor assay for botulinum neurotoxin B in food and human serum.
Ferracci G; Marconi S; Mazuet C; Jover E; Blanchard MP; Seagar M; Popoff M; Lévêque C
Anal Biochem; 2011 Mar; 410(2):281-8. PubMed ID: 21134347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
